alfuzosin has been researched along with Pain in 8 studies
alfuzosin: structure given in first source
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
Excerpt | Relevance | Reference |
---|---|---|
"To determine the efficacy and safety of the selective alpha(1)-blocker alfuzosin in men with lower urinary tract symptoms (LUTS) and painful ejaculation, compared with those with LUTS only, as painful ejaculation is one of the most prevalent, differentiating and bothersome symptoms in men with chronic prostatitis/chronic pelvic pain syndrome." | 9.12 | The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. ( Elhilali, M; Emberton, M; Nickel, JC; Vallancien, G, 2006) |
"The aim of this study is to evaluate the efficacy of alfuzosin with methylprednisolone on expulsion and pain control of lower ureteral stones <10 mm in size." | 7.78 | Effects of alfuzosin with methylprednisolone for spontaneous expulsion and pain control of lower ureteral stone. ( Hwang, EC; Hwang, IS; Jung, SI; Kang, TW; Kim, MK; Kim, SO; Kwon, DD; Lu, JW; Park, K; Ryu, SB; Yu, HS, 2012) |
"To assess the spontaneous passage rate for patients being treated with alfuzosin 10mg daily after presenting with an acute ureteral stone compared with a control group, and to assess the respective pain control status." | 5.15 | Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial. ( Chau, LH; Fan, CW; Fung, BT; Li, JC; Li, MK; Tai, DC, 2011) |
"To determine the efficacy and safety of the selective alpha(1)-blocker alfuzosin in men with lower urinary tract symptoms (LUTS) and painful ejaculation, compared with those with LUTS only, as painful ejaculation is one of the most prevalent, differentiating and bothersome symptoms in men with chronic prostatitis/chronic pelvic pain syndrome." | 5.12 | The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. ( Elhilali, M; Emberton, M; Nickel, JC; Vallancien, G, 2006) |
"The aim of this study is to evaluate the efficacy of alfuzosin with methylprednisolone on expulsion and pain control of lower ureteral stones <10 mm in size." | 3.78 | Effects of alfuzosin with methylprednisolone for spontaneous expulsion and pain control of lower ureteral stone. ( Hwang, EC; Hwang, IS; Jung, SI; Kang, TW; Kim, MK; Kim, SO; Kwon, DD; Lu, JW; Park, K; Ryu, SB; Yu, HS, 2012) |
"Alfuzosin therapy was tolerable with only minor adverse effects (headache, dizziness, mild postural hypotension, and rhinitis)." | 2.80 | Alfuzosin treatment improves the rate and time for stone expulsion in patients with distal uretral stones: a prospective randomized controlled study. ( El Said, NO; El Wakeel, L; Kamal, KM; Morad, Ael R, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jian, Z | 1 |
Chen, Y | 1 |
Liu, Q | 1 |
Liao, B | 1 |
Yang, T | 1 |
Li, H | 1 |
Wang, K | 1 |
El Said, NO | 1 |
El Wakeel, L | 1 |
Kamal, KM | 1 |
Morad, Ael R | 1 |
Kwon, JK | 1 |
Cho, KS | 1 |
Oh, CK | 1 |
Kang, DH | 1 |
Lee, H | 1 |
Ham, WS | 1 |
Choi, YD | 1 |
Lee, JY | 1 |
Chau, LH | 1 |
Tai, DC | 1 |
Fung, BT | 1 |
Li, JC | 1 |
Fan, CW | 1 |
Li, MK | 1 |
Hwang, EC | 1 |
Hwang, IS | 1 |
Yu, HS | 1 |
Kim, SO | 1 |
Jung, SI | 1 |
Kang, TW | 1 |
Kwon, DD | 1 |
Park, K | 1 |
Ryu, SB | 1 |
Kim, MK | 1 |
Lu, JW | 1 |
van Moorselaar, RJ | 1 |
Hartung, R | 1 |
Emberton, M | 2 |
Harving, N | 1 |
Matzkin, H | 1 |
Elhilali, M | 2 |
Alcaraz, A | 1 |
Vallancien, G | 2 |
Nickel, JC | 1 |
Vela-Casasempere, P | 1 |
Borras-Blasco, J | 1 |
Navarro-Ruiz, A | 1 |
2 reviews available for alfuzosin and Pain
Article | Year |
---|---|
Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Network Meta-Analysis; Pain; Quinaz | 2019 |
The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo.
Topics: Adrenergic alpha-Antagonists; Bayes Theorem; Humans; Pain; Pain Measurement; Quinazolines; Randomize | 2015 |
4 trials available for alfuzosin and Pain
Article | Year |
---|---|
Alfuzosin treatment improves the rate and time for stone expulsion in patients with distal uretral stones: a prospective randomized controlled study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Female; Humans; Male; Middle Aged; Pain; Prosp | 2015 |
Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, | 2011 |
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.
Topics: Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Pain; Penile Erection; Quality of Lif | 2005 |
The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
Topics: Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Pain; Prostatic Hyperpla | 2006 |
2 other studies available for alfuzosin and Pain
Article | Year |
---|---|
Effects of alfuzosin with methylprednisolone for spontaneous expulsion and pain control of lower ureteral stone.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Drug Therapy, Combination; Female; | 2012 |
Alfuzosin-associated dermatomyositis.
Topics: Adrenergic alpha-Antagonists; Aged; Dermatomyositis; Humans; Magnetic Resonance Imaging; Male; Muscl | 1998 |